Results 1 -
10
of
194
for
Lambrolizumab OR "MK-3475" OR Pembrolizumab
- Pembrolizumab Secures FDA Approval in Stomach Cancer (National Cancer Institute)FDA has approved the immunotherapy drug pembrolizumab (Keytruda®) for use in some patients with advanced gastric (stomach) cancer that is PD-L1 positive.
- Advances in Melanoma and Other Skin Cancers Research (National Cancer Institute)Find what's new in melanoma and other skin cancers research, including current progress in targeted therapies, immune checkpoint inhibitors, and adoptive ...
- Immunotherapy Drugs Expand Treatment Options for Advanced Lung Cancer (National Cancer Institute)... clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with advanced ...
- Targeted Therapy - Immunotherapy Combinations Effective for Advanced Kidney Cancer (National Cancer Institute)Kidney Cancer/Statistics and Research ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... For patients with advanced kidney cancer, ...
- Drugs Approved for Skin Cancer (National Cancer Institute)This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer. The list includes generic names and brand names. The drug ...
- Treatment Option Overview (Renal Cell Cancer) (National Cancer Institute)Kidney Cancer/Treatments and Therapies ... Kidney Cancer ... Renal cell cancer treatment options include surgery, radiation therapy, chemotherapy, biologic therapy, ...
- Stages of Renal Cell Cancer (National Cancer Institute)Kidney Cancer/Diagnosis and Tests ... Kidney Cancer ... Renal cell cancer treatment options include surgery, radiation therapy, chemotherapy, biologic therapy, ...
- General Information about Renal Cell Cancer (National Cancer Institute)Kidney Cancer/Start Here ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... Renal cell cancer treatment options include surgery, ...
- Advances in Lung Cancer Research (National Cancer Institute)Learn what's new in lung cancer research through recent findings from studies that used immunotherapy and targeted therapies to treat lung cancer. Find ...
- Triple-Negative Breast Cancer (Living Beyond Breast Cancer)Breast Cancer/Specifics ... Breast Cancer ... Living Beyond Breast Cancer ... About 10% to 15% of breast cancers are triple-negative. Learn more about the symptoms, ...